$BOXL update;
We’ve had a nice move from $1.80 to $2.37 yesterday thus far for a nice 32% trade. 💸
Price unfortunately hit a strong resistance level, the daily 200 EMA, an area where price previously rejected as well. (red line)
For now, we want to see the structure hold
$VNDA
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia.
Intraday flag breakout here plus this was given a price target of $24.00 by HC Wainwright this morning! 💰
Keep eyes for a multi-day move